
|Articles|December 23, 2021
Daily Medication Pearl: Xanax (Alprazolam)
Author(s)Saro Arakelians, PharmD
Xanax is indicated for the acute treatment of generalized anxiety disorder and treatment of panic disorder with or without agoraphobia in adults.
Advertisement
Medication Pearl of the Day: Xanax (Alprazolam)
Indication: Xanax is a benzodiazepine indicated for the acute treatment of generalized anxiety disorder and treatment of panic disorder with or without agoraphobia in adults.
Insight:
- Dosing: The recommended starting oral dosage for Xanax is 0.25 mg to 0.5 mg taken 3 times daily.
- Dosage forms: Xanax tablets come in dosage forms at 0.25 mg, 0.5 mg, 1 mg, and 2 mg.
- Adverse events (AEs): The most common AEs associated with the use of Xanax include impaired coordination, hypotension, dysarthria, and increased libido.
- Mechanism of action: Xanax is a 1,4 benzodiazepine. Xanax exerts its effect for the acute treatment of generalized anxiety disorder and panic disorder through binding to the benzodiazepine site of gamma-aminobutyric acid-A (GABAA) receptors in the brain and enhances GABAA-mediated synaptic inhibition.
- Manufacturer: Pfizer
Source:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Estradiol-Containing MHT May Impact Alzheimer Disease-Related Biomarkers in Postmenopausal Women
2
Axatilimab: A New Frontier for Steroid-Refractory Chronic GVHD
3
CHEST 2025: Exploring the Link Between GLP-1 Receptor Agonists, Type 2 Diabetes, and Asthma Risk
4
World Standards Week 2025: Advancing Quality and Patient Safety Standards to Shape Pharmacy Practice and Innovation
5